BCO
The Brink's Company
BCO's fundamentals are mixed: revenue grew 7.3%, but free cash flow fell 12%. At 31x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
BCO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BCO's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
BCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $117 | — |
| Cheap | 22x | $84.90 | -27% |
| Fair | 31x | $117 | +0.3% |
| Current | 31x | $117 | — |
| Expensive | 91x | $346 | +196% |
Historical ranges are pointers, not guarantees.
BCO's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
BCO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BCO's earnings to grow and its profitability to improve, with its revenue holding steady.
BCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.35 | +145% |
| Q3 2026 | $3.81 | -3.3% |
| Q2 2026 | $4.32 | +16% |
| Q1 2026 | $4.28 | +15% |
| Q4 2025 | $4.69 | +29% |
| Q3 2025 | $3.94 | +48% |
| Q2 2025 | $3.73 | +25% |
| Q1 2025 | $3.72 | +41% |
| Q4 2024 | $3.63 | +94% |
BCO earned $3.81 per share over the past year, down 3.3% from the year before.
BCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +3% |
| Q2 2026 | $1.4B | +7.1% |
| Q1 2026 | $1.4B | +10% |
| Q4 2025 | $1.4B | +9.1% |
| Q3 2025 | $1.3B | +6.1% |
| Q2 2025 | $1.3B | +3.8% |
| Q1 2025 | $1.2B | +0.9% |
| Q4 2024 | $1.3B | +1.5% |
BCO's revenue has grown year over year every quarter since late 2020: $1.4B last quarter, up 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.5% | -1.9 points |
| Q2 2026 | 9.6% | -0.7 points |
| Q1 2026 | 8% | -1.5 points |
| Q4 2025 | 13% | +4.8 points |
| Q3 2025 | 11% | +2.6 points |
| Q2 2025 | 10% | +1 points |
| Q1 2025 | 9.6% | -0.2 points |
| Q4 2024 | 8.3% | +0.1 points |
BCO's operating margin was 9.5% last quarter, down 1.9 points from the same quarter a year ago.
BCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.4M | -32% |
| Q2 2026 | $1.7M | -99% |
| Q1 2026 | -$11.4M | +$107.7M |
| Q4 2025 | $325.9M | +6.1% |
| Q3 2025 | $77.4M | +946% |
| Q2 2025 | $152.2M | +$275M |
| Q1 2025 | -$119.1M | -1118% |
| Q4 2024 | $307.2M | -9.6% |
BCO still generates free cash flow, though less than at its 2023 peak: $369M over the past year.
BCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.4% | -600K shares |
| 3 years | -12% | -5.6M shares |
| 5 years | -17% | -8.8M shares |
| Available history | -19% | -9.6M shares |
BCO has 42M diluted shares, down 1.4% from a year ago, with $86M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $30.2M |
| Q4 2025 | $55.8M |
| Q3 2025 | $23.6M |
| Q2 2025 | $85.2M |
| Q1 2025 | $44.8M |
| Q4 2024 | $78.3M |
BCO spent $86M buying back its own shares over the past year, down 63% from the year before.
BCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Moderate |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 2.8x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.4x | Elevated |
BCO's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
BCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.0 | Neutral |
| Stochastic | 53.4 | Neutral |
BCO's weekly RSI is 57 (neutral) and its Stochastic is 53 (neutral).
BCO PE vs Industrials Sector
| Metric | BCO | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 28% above |
| PE % | 49 | 58 | 9 pts below |
BCO is trading at 31x earnings, a 28% premium to the Industrials sector's median of 24x.
BCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.3 | 9.1% above |
| 20 week MA | $110.0 | 6.3% above |
| 50 week MA | $111.7 | 4.7% above |
| 100 week MA | $104.4 | 12% above |
| 200 week MA | $94.0 | 24% above |
BCO is in an uptrend: it's above all five of its weekly moving averages, and 24% above its 200-week average.
BCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $91.1 | $70.8 | -22% |
| 2021 | $70.8 | $64.7 | -8.6% |
| 2022 | $64.7 | $54.1 | -16% |
| 2023 | $54.1 | $88.0 | +63% |
| 2024 | $88.0 | $91.7 | +4.3% |
| 2025 | $91.7 | $119.6 | +30% |
| 2026 YTD | $119.6 | $117.0 | -2.2% |
BCO has finished lower in three of the last six years. It's down 2.2% so far in 2026.